Literature DB >> 12355370

Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.

Mark Schiffman1, Cosette M Wheeler, Philip E Castle.   

Abstract

Cervical human papillomavirus (HPV) infections are at high risk of neoplastic progression if they persist. Persistence can be measured by repeated HPV DNA tests or by cytologic testing. Thus, it is useful to understand the relationship between these 2 measurements. To explore the relative timing of HPV DNA clearance versus cytologic regression, data were analyzed from 840 study participants who were followed-up by repeat thin-layer cytology and HPV testing by a hybrid capture test at 6-month intervals for 2 years. On average, HPV DNA detection persisted longer than related cytologic abnormalities (P<.001). HPV type-specific data from a subset of 448 women with complete polymerase chain reaction test data confirmed that HPV DNA persisted longer than cytologic abnormalities (P<.001). It appears that the natural history of HPV typically includes periods before and after cytologic abnormality, in which HPV DNA is the more sensitive indicator of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12355370     DOI: 10.1086/343816

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting.

Authors:  Sarah Coseo Markt; Ana C Rodriguez; Robert D Burk; Allan Hildesheim; Rolando Herrero; Sholom Wacholder; Martha Hutchinson; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Cervical screening and cervical cancer death among older women: a population-based, case-control study.

Authors:  Alison S Rustagi; Aruna Kamineni; Sheila Weinmann; Susan D Reed; Polly Newcomb; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2014-03-30       Impact factor: 4.897

Review 3.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

4.  Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

Authors:  Wim G V Quint; Sonia R Pagliusi; Nico Lelie; Ethel-Michele de Villiers; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.

Authors:  Yongjung Park; Eunhee Lee; Jonghyeon Choi; Seri Jeong; Hyon-Suk Kim
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

6.  AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections.

Authors:  Judith A Smith; Anjali A Gaikwad; Lata Mathew; Barbara Rech; Jonathan P Faro; Joseph A Lucci; Yu Bai; Randall J Olsen; Teresa T Byrd
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

7.  Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

Authors:  Matthew P Stevens; Suzanne M Garland; Elice Rudland; Jeffrey Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

8.  Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union.

Authors:  Stina Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Piero Tosi; Marcella Cintorino; Rosa Santopietro; Kari Syrjänen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

9.  High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women.

Authors:  Angela Watt; David Garwood; Maria Jackson; Novie Younger; Camille Ragin; Monica Smikle; Horace Fletcher; Norma McFarlane-Anderson
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

10.  A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs.

Authors:  Maria Demarco; Noorie Hyun; Olivia Carter-Pokras; Tina R Raine-Bennett; Li Cheung; Xiaojian Chen; Anne Hammer; Nicole Campos; Walter Kinney; Julia C Gage; Brian Befano; Rebecca B Perkins; Xin He; Cher Dallal; Jie Chen; Nancy Poitras; Marie-Helene Mayrand; Francois Coutlee; Robert D Burk; Thomas Lorey; Philip E Castle; Nicolas Wentzensen; Mark Schiffman
Journal:  EClinicalMedicine       Date:  2020-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.